These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33400854)

  • 61. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
    Yoshioka Y; Suzuki T; Matsuo Y; Nakakido M; Tsurita G; Simone C; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
    Oncotarget; 2016 Nov; 7(46):75023-75037. PubMed ID: 27626683
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads.
    D'Annessa I; Sattin S; Tao J; Pennati M; Sànchez-Martìn C; Moroni E; Rasola A; Zaffaroni N; Agard DA; Bernardi A; Colombo G
    Chemistry; 2017 Apr; 23(22):5188-5192. PubMed ID: 28207175
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.
    McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA
    SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
    Colón-Bolea P; Crespo P
    Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SMYD3 activates the TCA cycle to promote M1-M2 conversion in macrophages.
    Zhu W; Liu L; Wu J; Gao R; Fu L; Yang X; Zou Y; Zhang S; Luo D
    Int Immunopharmacol; 2024 Jan; 127():111329. PubMed ID: 38091832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
    Donnelly A; Blagg BS
    Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
    [TBL] [Abstract][Full Text] [Related]  

  • 69. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
    Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
    Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
    Zhang XD; Huang GW; Xie YH; He JZ; Guo JC; Xu XE; Liao LD; Xie YM; Song YM; Li EM; Xu LY
    Nucleic Acids Res; 2018 Feb; 46(4):1793-1809. PubMed ID: 29253179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
    Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
    Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer.
    Ikram S; Rege A; Negesse MY; Casanova AG; Reynoird N; Green EM
    Sci Adv; 2023 Nov; 9(46):eadi5921. PubMed ID: 37976356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A methylated lysine is a switch point for conformational communication in the chaperone Hsp90.
    Rehn A; Lawatscheck J; Jokisch ML; Mader SL; Luo Q; Tippel F; Blank B; Richter K; Lang K; Kaila VRI; Buchner J
    Nat Commun; 2020 Mar; 11(1):1219. PubMed ID: 32139682
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Notch ligand Delta-like 4 induces epigenetic regulation of Treg cell differentiation and function in viral infection.
    Ting HA; de Almeida Nagata D; Rasky AJ; Malinczak CA; Maillard IP; Schaller MA; Lukacs NW
    Mucosal Immunol; 2018 Sep; 11(5):1524-1536. PubMed ID: 30038214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination.
    Zhang L; Jin Y; Yang H; Li Y; Wang C; Shi Y; Wang Y
    Carcinogenesis; 2019 Dec; 40(12):1492-1503. PubMed ID: 31002112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates the Diversity of Protein Responses and Ligand-Specific Functional Mechanisms.
    Astl L; Stetz G; Verkhivker GM
    J Chem Theory Comput; 2020 Oct; 16(10):6656-6677. PubMed ID: 32941034
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New open conformation of SMYD3 implicates conformational selection and allostery.
    Spellmon N; Sun X; Xue W; Holcomb J; Chakravarthy S; Shang W; Edwards B; Sirinupong N; Li C; Yang Z
    AIMS Biophys; 2017; 4(1):1-18. PubMed ID: 28050603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells.
    Ren TN; Wang JS; He YM; Xu CL; Wang SZ; Xi T
    Med Oncol; 2011 Dec; 28 Suppl 1():S91-8. PubMed ID: 20957523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications.
    Rubio-Tomás T
    Mol Biol Rep; 2021 Nov; 48(11):7499-7508. PubMed ID: 34510321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase.
    Pereira D; Richert A; Medjkane S; Hénon S; Weitzman JB
    Sci Rep; 2020 Nov; 10(1):20598. PubMed ID: 33244033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.